Big Week Ahead For Stocks… And Emergent’s Mpox Approval 8/30/24

August trading is in the books, and after a rough start to the month, stocks managed to rebound. But with a big week on deck, can the bounce back continue? Plus Biotech company Emergent Bio getting FDA approval for its smallpox vaccine to treat mpox. What it could mean for Emergent’s future and the space as a whole. Fast Money Disclaimer Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Episode metadata supplied by the publisher feed · Published Aug 30, 2024

Embed this episode

Attribution link and audio player

NOW PLAYING

Big Week Ahead For Stocks… And Emergent’s Mpox Approval 8/30/24

0:00 43:51

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of CNBC's "Fast Money"?

This episode is 43 minutes long.

When was this CNBC's "Fast Money" episode published?

This episode was published on August 30, 2024.

Can I download this CNBC's "Fast Money" episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!